![Stefan Sperl](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stefan Sperl
Directeur des opérations chez KIORA PHARMACEUTICALS, INC.
Provenance du réseau au premier degré de Stefan Sperl
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 8 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Stefan Sperl via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Wake Forest University | College/University | Undergraduate Degree Undergraduate Degree | |
Bayon Therapeutics, Inc. | Founder Founder | ||
Ora, Inc.
![]() Ora, Inc. Medical/Nursing ServicesHealth Services Ora, Inc. provides ophthalmic services. It engages in the provision of ophthalmic services and it specializes in allergy, allergic rhinitis, dry-eye, retina, anti-infective, anti-inflammatory, glaucoma, drug delivery, and ophthalmic devices. The firm offers development services including preclinical models, clinical research and development, regulatory strategy, statistics and data management, medical writing, and marketing and advertising. The company was founded by Mark Barry Abelson in 1985 and is headquartered in Andover, MA. | Medical/Nursing Services | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Okogen, Inc.
![]() Okogen, Inc. Miscellaneous Commercial ServicesCommercial Services Okogen, Inc. engages in the development of clinical theraphies to serve the needs of adult and children with ocular infections. Its lead candidate, OKG-0301, is a ribonuclease which targets degradation of specific tRNA and miRNA, which leads to inhibiting protein synthesis. It stops viral replication and shortens the duration of infection. The company was founded on July 1, 2016 and is headquartered in Encinitas, CA. | Miscellaneous Commercial Services | Founder Founder | |
ALIMERA SCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
University of Pennsylvania Medical Center | College/University | Doctorate Degree | |
Johnson Graduate School of Management | College/University | Masters Business Admin | |
CONTINEUM THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
Neomorph, Inc.
![]() Neomorph, Inc. Pharmaceuticals: MajorHealth Technology Neomorph, Inc. is an American venture-backed biotechnology company that focuses on discovering innovative new medicines against 'undruggable' targets to solve critical problems in human health. The company is headquartered in an undisclosed location and has a key collaboration with the Center for Protein Degradation at the Dana Farber Cancer Institute. Neomorph's team is comprised of industry-leading experts in protein degradation and molecular glues who are committed to advancing the science and technology of molecular glue drug discovery. The company's patient-first, science-driven approach is complemented by its dedication to a supportive and collaborative work environment. Neomorph was founded by Eric Fischer, Philip Chamberlain, Scott A. Armstrong, and Benjamin Ebert, with Philip Chamberlain serving as the CEO since incorporation. | Pharmaceuticals: Major | Director of Finance/CFO | |
Bates College | College/University | Undergraduate Degree | |
Infocus Capital Partners
![]() Infocus Capital Partners Investment ManagersFinance InFocus Capital Partners (InFocus Capital Partners) is a venture capital firm founded in 2016 by Rob Rothman and Ron Weiss. The firm is headquartered in Jericho, New York. | Investment Managers | Consultant / Advisor | |
Stanford University | College/University | Undergraduate Degree | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
AERIE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
ALLERGAN, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
REVANCE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Anderson School of Management | College/University | Masters Business Admin | |
Arnold & Mabel Beckman Foundation
![]() Arnold & Mabel Beckman Foundation Investment Trusts/Mutual FundsMiscellaneous Arnold & Mabel Beckman Foundation engages in the provision of support to young researchers. It focuses in the fields of chemistry and life sciences, broadly interpreted, and particularly to foster the invention of methods, instruments, and materials that open up new avenues of research and application in these sciences and related disciplines. It offers national programs and local community works. The company was founded by Arnold O. Beckman and Mabel Beckman in September 1977 and is headquartered in Irvine, CA. | Investment Trusts/Mutual Funds | Director/Board Member | |
Duke University
![]() Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Graduate Degree | |
Yellowbrick Bio LLC
![]() Yellowbrick Bio LLC Pharmaceuticals: MajorHealth Technology Part of Kiora Pharmaceuticals, Inc., Yellowbrick Bio LLC is a company that manufactures ophthalmological pharmaceutical products. The company is based in Solana Beach, CA. The company was founded in 2020 by Brian Matthew Strem. Yellowbrick Bio was acquired by Kiora Pharmaceuticals, Inc. on October 21, 2021 for $7.22 million. | Pharmaceuticals: Major | Founder | |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree | |
University of California, Los Angeles | College/University | Doctorate Degree | |
Parsons Medical Communications LLC
![]() Parsons Medical Communications LLC Miscellaneous Commercial ServicesCommercial Services Part of Fingerpaint Marketing, Inc., Parsons Medical Communications LLC is a scientific agency that specializes in the ophthalmics space. The company is based in St. Petersburg, FL. The company creates compelling, timely, and clinically relevant content to convey scientific messages to clinicians and strategic partners. The company also provides logistics management, advisory boards, KOL mapping/advocacy, and market assessments. The company was founded in 2010 by Erin E. Parsons, who has been the CEO since then. Parsons Medical Communications was acquired by Fingerpaint Marketing, Inc. on September 28, 2022. | Miscellaneous Commercial Services | Chief Executive Officer | |
University of California, Berkeley | College/University | Undergraduate Degree | |
David Geffen School of Medicine | College/University | Doctorate Degree | |
OccuRx Pty Ltd
![]() OccuRx Pty Ltd BiotechnologyHealth Technology OccuRx Pty Ltd provides biopharmaceutical services. It engages in the development of therapeutic strategies for the treatment of ophthalmic disorders associated with retinal fibrosis and inflammation. The company was founded by Darren J. Kelly in 2014 and is headquartered in Melbourne, Australia. | Biotechnology | Chief Executive Officer | |
Bausch & Lomb, Inc.
![]() Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Johnson & Johnson Pharmaceutical Research & Development LLC
![]() Johnson & Johnson Pharmaceutical Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Johnson & Johnson Pharmaceutical Research & Development LLC provides research and development support services. It offers drug discovery and drug development in a variety of therapeutic areas, including CNS, Internal Medicine and Oncology, to address unmet medical needs worldwide. The company is headquartered in Raritan, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Novartis Consumer Health, Inc.
![]() Novartis Consumer Health, Inc. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Novartis Consumer Health, Inc. manufactures and supplies pharmaceutical products. The company is based in Lincoln, NE. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Aronex Pharmaceuticals, Inc.
![]() Aronex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aronex Pharmaceuticals, Inc. develops proprietary medicines to treat cancer and infectious diseases. The company's products include Nyotran, Atragen, Annamycin, and Zintevir. It is headquartered in The Woodlands, TX. | Pharmaceuticals: Major | Chief Operating Officer | |
The Ohio State University
![]() The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Doctorate Degree | |
Banaras Hindu University | College/University | Undergraduate Degree | |
Interpath Pharmaceuticals, Inc.
![]() Interpath Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Interpath Pharmaceuticals, Inc. develops cancer therapeutics based on liposomal delivery technology for antisense. The company was founded in 2001 by Gabriel Lopez-Berestein and Peter Nielsen and is headquartered in Houston, TX | Pharmaceuticals: Major | Director/Board Member | |
Arsenal Capital Management LP
![]() Arsenal Capital Management LP Investment ManagersFinance Arsenal Capital Management LP (Arsenal Capital) is a private equity subsidiary of Arsenal Capital Group LLC founded in 2000 by Terrence M. Mullen and Jeffrey B. Kovach. The firm is headquartered in New York. | Investment Managers | Private Equity Analyst | |
ORIENT EUROPHARMA CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
The United States Pharmacopeia
![]() The United States Pharmacopeia Pharmaceuticals: MajorHealth Technology The United States Pharmacopeia engages in manufacturing medicines. It offers dietary supplements, and foods. The company is headquartered in Rockville, MD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Osmotica Pharmaceutical Corp.
![]() Osmotica Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Osmotica Pharmaceutical Corp. provides drug delivery technologies and neurology based therapies. It develops and commercializes a portfolio of products related to central nervous system disorders with a focus in Parkinson's disease and related neurological disorders. The company was founded in 1986 and is headquartered in Bridgewater, GA. | Pharmaceuticals: Major | Chief Executive Officer | |
LEXICON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Lipomedix Pharmaceuticals Ltd.
![]() Lipomedix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Lipomedix Pharmaceuticals Ltd. engages in the development of cancer therapy based on liposome delivery. It offers Promitil®, a proprietary formulation of a lipid-based pro-drug of MMC (MLP) which enables efficient delivery and release of active MMC to tumors in vivo. The company was founded by Alberto Gabizon and Rami Kremien and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member | |
Anadys Pharmaceuticals, Inc.
![]() Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | Sales & Marketing | |
RAMBODA FALLS PLC | Hotels/Resorts/Cruise lines | Director/Board Member | |
GI DYNAMICS, INC. | Medical Specialties | Director/Board Member | |
Invectys, Inc.
![]() Invectys, Inc. Pharmaceuticals: MajorHealth Technology Invectys, Inc. is a biopharmaceutical company that focuses on developing immunotherapy treatments for cancer. The private company is based in Houston, TX. Invectys was founded in 2010 and Praveen Tyle has been the CEO of the company since 2021. | Pharmaceuticals: Major | Chief Executive Officer | |
Invectys USA, Inc. | Chief Executive Officer | ||
SKYE BIOSCIENCE, INC. | Pharmaceuticals: Major | Director/Board Member | |
Maxwell Biosciences, Inc.
![]() Maxwell Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Maxwell Biosciences, Inc. operates as biotechnology company for optimizing cognitive performance and health span. The company was founded by Joshua McClure and Annelise Barron in 2016 and is headquartered in Austin, TX. | Miscellaneous Commercial Services | Director/Board Member |
Statistiques
Internationale
Etats-Unis | 44 |
Australie | 2 |
Canada | 2 |
Inde | 2 |
Taïwan | 2 |
Sectorielle
Health Technology | 25 |
Consumer Services | 16 |
Commercial Services | 5 |
Finance | 3 |
Health Services | 2 |
Opérationnelle
Director/Board Member | 26 |
Corporate Officer/Principal | 12 |
Chief Tech/Sci/R&D Officer | 9 |
Chief Executive Officer | 9 |
Undergraduate Degree | 8 |
Relations les plus connectées
Insiders | |
---|---|
Praveen Tyle | 23 |
Carmine Stengone | 11 |
David Hollander | 9 |
Eric Daniels | 7 |
Brian Strem | 6 |
Aron Shapiro | 4 |
Erin Parsons | 4 |
Melissa Tosca | 3 |
- Bourse
- Insiders
- Stefan Sperl
- Connexions Sociétés